ReviewWorld journal of clinical oncology2019

Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy.

Ozkan Kanat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.